Sage Journals: Discover world-class research

Retricted access

Review article

First published 2018-6

The adverse kidney effects of cancer immunotherapies

Danielle L Saly, Mark A Perazella

Journal of Onco-Nephrology

Open access

Research article

First published 2020

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG

Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2017-4

Immune Checkpoint Inhibitors in Malignancies with Mismatch Repair Deficiency: A Review of the State of the Current Knowledge

Ali Naboush, Christopher A J Roman, Iuliana Shapira

Journal of Investigative Medicine

Retricted access

Research article

First published 2022-6

Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysis

Alaa Shahbar, Majed Alshamrani, Mohammed Aseeri [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2023-7

International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions

Andrew Walker, Alexandre Chan, Constanza Cortés Labra [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2021

Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature

Yolanda Piña, Brittany R. Evernden, Nikhil Khushalani [...]

Sage Open Medical Case Reports

Open access

Review article

First published 2018

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system

Marinos C. Dalakas

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2023-2

A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)

Giuseppe Procopio, Mélanie Claps, Chiara Pircher [...]

Tumori Journal

Retricted access

Research article

First published 2023-1

Evaluation and clinical impact of a pharmacist-led,interdisciplinary service focusing on education,monitoring and toxicity management of immune checkpoint inhibitors

Glenn Myers, Jonathan Stevens, Andrew Flewelling [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2020-4

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Morgan E Gwynn, David L DeRemer, Katherine M Saunders [...]

Journal of Oncology Pharmacy Practice

Search results